[63, 65, 67, 68, 72, 78, 83] While interesting pre-clinical data of other potential targets for ACC (e.g., steroidogenic factor 1, c-Met pathway, estrogen receptors, DNA methylation) are emerging, an expansion of immunotherapy translational studies would also be desirable.[92, 106, 109, 116, 131]. The gene discussed is MET; the disease is adrenal cortex carcinoma.